Penn Medicine presenter at ISHLT 2024 in Prague

PHILADELPHIA – Penn Medicine’s leading experts in lung and heart transplantation will gather in Prague from April 10-13 for ISHLT’s annual conference. Pennsylvania experts dig into the latest in advanced cardiopulmonary disease and transplantation, connecting with colleagues around the world. “We are very pleased to see so many professionals wanting to take part in this global event, share their knowledge and collaborate with colleagues around the world. “This is a really exciting opportunity to be on stage and contribute to the advancement of this field.” Jason Christie, MD, MSc; He is the chief of the Division of Pulmonary, Allergy, and Critical Care at the University of Pennsylvania and the current president of ISHLT. “ISHLT2024 promises to be an unparalleled gathering in the field of heart and lung transplantation.”

ISHLT2024 presenter

Below are some of the topics presented by Penn experts this year.

Jason Christie, MD, MS, Chief of the Division of Pulmonary, Allergy, and Critical Care at the University of Pennsylvania

Session: ISHLT Chairman Report

Time and Location: April 10, 2024, 8:13 a.m. – 8:33 a.m., Congress Hall

Mr. Christie will detail the groundbreaking advances in heart and lung transplantation over the past year and highlight ISHLT’s pivotal role in driving innovation across research, clinical care, and education. Mr. Christie announced the creation of a new Strategic Investment Fund, which will feature cutting-edge research grants totaling more than $1 million from the newly created ISHLT Foundation. He will address pressing issues such as normothermic regional perfusion, special issues regarding the pediatric-to-adult transition in transplantation and advanced equipment for heart and lung failure, and the need for transplantation and mechanical circulatory support therapy around the world. Find out more about how the new task force is working on issues such as equity of access.

Elliot Peister, MD, MSc, Assistant Professor of Cardiovascular Medicine

Session: Through New Eyes: Computer Vision Applied to Heart and Lung Biopsies

Date and location: April 10, 2024, 10:15 a.m. to 10:30 a.m. Panorama Hall

Mr. Peyster’s talk will explore the value of computer vision/machine learning applied to endocardial and lung biopsy slides. We discuss the opportunities and challenges of applying image-based machine learning tools to clinical practice.

Edward Cantu, MD, MSc, Professor of Surgery, Hospital of the University of Pennsylvania

Session: Discussion: Composite Allocation Score – Better than ever, CAS is the best

Date, Time and Location: April 10, 2024, 1:45pm-2:00pm, South Hall 1

Cantu supports the newly introduced Composite Allocation Score (CAS) in lung transplantation, highlighting improvements to the LAS system, particularly related to reducing waitlist mortality, and says the composite score structure will continue to improve. We will explain how it is suitable for you.

Dr. Joyce Wald, Professor of Cardiovascular Medicine

Session: Community systems of care can improve outcomes in cardiogenic shock: Penn Medicine Shock Team and community relationships

Date, time and location: April 10, 2024, 6:00pm – 7:00pm, Poster Hall

Although patients with cardiogenic shock often face a poor prognosis, a multidisciplinary approach to care may lead to early introduction of advanced treatments and improve outcomes. Founded in 2019, the Penn Medicine Shock team values ​​two-way communication with our community partners, resulting in strong relationships and increased referrals.

Michael Anderson, MD, Assistant Professor, Department of Respiratory, Allergy, and Critical Care Medicine

Session: Quantifying body composition in lung transplantation: Is BMI the best we can do?

Time and Location: April 12, 2024, 8:39 a.m. – 8:51 a.m., Congress Hall

Obesity increases the risk of PGD and death after lung transplantation, whereas weight loss may improve survival after transplantation. Professor Anderson will review the data supporting the use of BMI in candidate selection and discuss alternative measures of body composition-related risk in lung transplant candidates. Mr. Anderson will also discuss some of the physiological/biological mechanisms of obesity and how obesity is related to inflammation.

David Rekhtman, medical student at Perelman School of Medicine

Session: Effect of donor distance on post-transplant mortality

Time and Location: April 12, 2024, 3:30pm – 3:40pm, Capitol Building

Rechtman compares post-transplant mortality rates based on the distance between donor and transplant center. Under the U.S.’s new heart transplant allocation system, certain patients are eligible to receive a heart transplant from a donor radius greater than 250 miles. Little has been reported about the safety of long-distance travel and its impact on ischemic time.

Dr. Emily Bayle, MD, Assistant Professor of Anesthesiology and Critical Care

Session: Outcomes of Lung Transplant Transplantation from Organs Recovered in Independent Donor Care Units and Hospital-Based Donor Care Units

Time and Location: April 12, 2024, 5:06pm – 5:10pm, Panorama Hall

In the United States, deceased organ donors are managed for organ recovery in one of two types of donor care units (DCUs): freestanding and hospital-based. Delivery and porting outcomes have not been compared between these types, as staffing, resources, and management processes may differ. Vail and his team of researchers hypothesized that there would be no difference in lung graft survival between donors in independent and hospital-based DCUs.

For a complete list of speakers and presentation titles, please visit: ISHLT2024 website.

interview request

To speak with Jason Christie, MD, MSc, or other attending experts from the Perelman School of Medicine, email Penn Medicine spokesperson Matt Toal at matthew.toal@pennmedicine.upenn.edu please.

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of: University of Pennsylvania Health System and Mr. Penn’s Raymond and Ruth Perelman School of MedicineIt was established in 1765 as the first medical school in Japan.

Perelman School of Medicine consistently ranks among the nation’s top recipients of National Institutes of Health funding, with $550 million awarded in fiscal year 2022. With an illustrious history of firsts in medicine, the Penn Medicine team continues to advance modern technology, including recent breakthroughs such as CAR T-cell therapy for cancer and mRNA technology used in COVID-19 vaccines. It has pioneered discoveries and innovations that have shaped medicine.

The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the coast of New Jersey. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Hospital, Penn Medicine Princeton Health, and Pennsylvania Hospital, the first hospital in the United States, founded in 1751. Other facilities and companies include Good Shepherd Penn His Partners. , Penn Medicine at Home, Lancaster Behavioral Health Hospital, Princeton House Behavioral Health, and more.

Penn Medicine is an $11.1 billion company supported by more than 49,000 talented faculty and staff.